| 22726 | PC | Packed Red Blood Cells | Packed Cells, Leukoreduced Red Cells, LRBC, RBC, PRBC | ABO/RH, ABSC, CROSSMATCH | | 24709 | PCS10 | Pain Clinic Drugs with Confirmation | Amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, ethanol, methadone, opiates, oxycodone, buprenorphine, Clonazepam, Temazepam, Diazepam, Chlordiazepoxide, Alprazolam, Flunitrazepam, Flurazepam, Nordiazepam, Chlorazepate, Marijuana, THC, Benzoylecgonine, Cocaine, Hydromorphone, Hydrocodone, Morphine, Codeine, Oxymorphone, Oxycodone, Oxycontin, Vicodin, Amines | Immunoassay screen with quantitative confirmation by gas or liquid chromatography methods (when needed) for the following drug classes or method groups: amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, opiate method group, oxycodone method group, and buprenorphine. Test also includes specimen validity testing (creatinine, pH, and oxidants) to detect adulteration, dilution, or substitution of the specimen. Immunoassay screen for ethanol with quantitative result.
The immunoassay screening test for the Benzodiazepines drug class does not detect Lorazepam or Clonazepam well. If either of these drugs are suspected, please order the test “Benzodiazepines, Urine, Confirm Only by LC/MSMS” in addition to this test to insure detection if present. | | 24763 | PCSMIN | Pain Clinic Drugs with Confirmation - Mini, Urine | Cannabinoids, Cocaine, Methadone, Opiates, Oxycodone, Marijuana, THC, Benzoylecgonine, Cocaine, Hydromorphone, Hydrocodone, Morphine, Codeine, Oxycontin, Vicodin | Immunoassay screen quantitative confirmation by gas or liquid chromatography methods (when needed) for the following drug classes or method groups: cannabinoids, cocaine metabolite, methadone method group, opiate method group, and oxycodone method group. Test also includes specimen validity testing (creatinine, pH, and oxidants) to detect adulteration, dilution, or substitution of the specimen. | | 24726 | PCS10WO | Pain Clinic Drugs without Confirmation | amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, ethanol, methadone, opiates, oxycodone, buprenorphine | Immunoassay screen for the following drug classes or method groups: amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, ethanol, methadone, opiate method group, oxycodone, and buprenorphine. Test also includes specimen validity testing (creatinine, pH, and oxidants) to detect adulteration, dilution, or substitution of the specimen.
The immunoassay screening test for the Benzodiazepines drug class does not detect Lorazepam or Clonazepam well. If either of these drugs are suspected, please order the test “Benzodiazepines, Urine, Confirm Only by LC/MSMS” in addition to this test to insure detection if present. | | 26153 | PCS4WO | Pain Clinic Survey 4 Without Confirmation, Urine | Drug screen, drug test, barbiturates, cannabinoids, marijuana, THC, cocaine, ethanol | Immunoassay screen for the following drug classes or method groups: barbiturates, cannabinoids, cocaine, and ethanol. Test also includes specimen validity testing (creatinine, pH, and oxidants) to detect adulteration, dilution, or substitution of the specimen.
Results of this test are presumptive. If confirmatory testing is desired, the confirmatory test(s) can be ordered as add-on (u-have) tests, utilizing the original urine collection, within 9 days of the original test.
This test is intended to compliment the test “Targeted Drug Panel, Urine” (TDPU).
| | 24932 | PE1SO | Pancreatic Elastase, Fecal (123234) | PE1, Elactase, Pancreatic | | | 24817 | HPPSO | Pancreatic Polypeptide, Plasma (HPP) | HPP (Human Pancreatic Polypeptide), Human Pancreatic Polypeptide, PP (Pancreatic Polypeptide,Plasma) | | | 23152 | PARASO | Paraneoplastic Autoantibody Evaluation, Serum (PAVAL) | AGNA, Amphiphysin Antibody, Serum, ANNA (Antineuronal Nuclear Antibody), Anti-CV2, Anti-Enteric Neuronal Antibody, Anti-GAD65 (Anti-Glutamic Acid Decarboxylase), Anti-Glial Nuclear Antibody, Anti-Hu, Anti-Purkinje Cell Cytoplasmic Antibodies, Anti-Ri, Anti-Yo, Antineuronal, APCA (Anti-Purkinje Cell Antibodies), Calcium Channel Blockers, Cerebellar Antibodies, Chorea, Cramp-fasciculation, CRMP-5, IgG, Dorsal Root Ganglion Antibody, Glutamate Decarboxylase Antibodies (GAD65), Hu Antibody, Motor End-Plate Antibody, Motor Nerve Terminal Antibodies, Myoid Antibody, N-Type Calcium Channel Antibody, Neuromyotonia, Neuronal Nuclear Antibody, Neuronal Nuclear Antibody Panel, Neuronal Potassium Channel Ab, Neuronal-Anti, Ovarian Cancer-Related Antibodies, P/Q Type Calcium Channel Antibody, Paraneoplastic Antibodies, Paraneoplastic Autoantibody Evaluation, Paraneoplastic Neurological Autoimmunity, PCA-1 (Purkinje Cell Cytoplasmic Antibodies), PCA-2 (Purkinje Cell Cytoplasmic Antibodies), PCA-Tr (Purkinje Cell Cytoplasmic Antibodies), PCAb (Purkinje Cell Cytoplasmic Antibodies), Potassium Channel Antibodies (specify), Purkinje Cell Cytoplasmic Antibodies, Type 1, Purkinje Cell Cytoplasmic Antibodies, Type 2, Purkinje Cell Cytoplasmic Antibodies, Type Tr, Ri, Anti, Stiff-man Syndrome, VGCC (Voltage-Gated Calcium Channel) Antibodies, VGKC, VGPC, Voltage-Gated Potassium Channel Ab, Yo-Anti ,Neuronal Ganglionic Acetylcholine Receptor Antibody, Cantoxin Receptor Antibodies, Collapsin Response-Mediator Protein-5 Antibody (CRMP-5), Isaacs Disease, Neuromuscular Hyperexcitability, Purkinje Cell Cytoplasmic Antibodies, Alpha-3 | | | 23103 | IOPTH | Parathyroid Hormone, Intraoperative Rapid | Parathyroid Surgery Only, IOPTH | | | 25487 | MISC | Parechovirus PCR, CSF | Entero-Parechovirus, HPeV, Enterovirus | | | 26014 | PPAPSO | Parental Prenatal Array Prep Test (PPAP) | | | | 22759 | APTT | Partial Thromboplastin Time - APTT/PTT | PTT, APTT, Activated Partial Thromboplastin Time | | | 22758 | PTTLA | Partial Thromboplastin Time - Lupus Anticoagulant (PTTLA) | PTT-LA, Lupus Anticoagulant PTT, APTT-LA, StaClot LA | | | 26116 | PARVSSO | Parvovirus B19 Antibodies, IgG and IgM, Serum (PARVS) | B19
Erythrovirus B19
Fifth Disease
Human Parvovirus Slapped Cheek disease | Parvovirus B19 IgG & IgM Antibodies with Interpretation | | 23392 | MISC | Parvovirus B19, DNA Detection by Rapid PCR (PARVO) | B19, Erythrovirus B19, Fifth Disease-Parvovirus, Human Parvovirus B19, Parvovirus B19 PCR, Parvovirus PCR, Parvovirus-Fifth Disease | | | 26054 | PARVPSO | Parvovirus B19, PCR, Plasma (PARVP) | B19, Erythrovirus B19, Fifth Disease-Parvovirus, Human Parvovirus B19, Parvovirus B19 PCR, Parvovirus PCR, Parvovirus-Fifth Disease | | | 25082 | PCA3SO | PCA3 (FPPCA) | Differential Display Code 3 (DD3), PCA3 (Prostate Cancer Antigen 3), PCA3, PCA-3, Prostate Cancer Gene 3 | | | 25646 | PDL1SO | PD-L1 22C3, IHC (KEYTRUDA) | NOTE: This test is only for internal use only. It is active in the Lab System only – and will need to be manually entered via LOM if needed.
PD-L1, PDL1, 22C3, KEYTRUDA, pembrolizumab, IHC, Immunohistochemistry | | | 25648 | MISCTIS | PD-L1 28-8 FDA (OPDIVO/Nivolumab) | PD-L1, PDL1, 28-8 FDA, CHECKMATE, OPDIVO | | | 25649 | MISCTIS | PD-L1, SP142 FDA (TECENTRIQ/atezolizumab) IHC | PD-L1, PDL1, SP142, TECENTRIQ, ATEZOLIAUMAB, IHC, Immunohistochemistry | | | 22762 | HD-PDF | Peritoneal Equilibration Test | Hemodialysis PDF, Glu/Creat/UreaN | Glucose, Creatinine, and Urea Nitrogen | | 22763 | MISC | Peroxidase Stain | Myeloperoxidase | | | 26288 | APH | pH, Arterial | | | | 22764 | MISC | PH, Blood | | | | 22765 | PH-BF | pH, Body Fluid | | | | 22766 | PH-O | PH, Fecal | Stool for pH, Fecal pH | | | 22767 | PH-U | PH, Urine Qualitative | | | | 26289 | VPH | pH, Venous | | | | 22769 | PHENO | Phenobarbital | Phenobarb | | | 26097 | PKUSO | Phenylalanine and Tyrosine, Plasma (PKU) | Phenylalanine Includes Tyrosine
PKU (Phenylketonuria)
Tyrosine
Tyrosinemia
Hyperphenylalaninemia
| Phenylalanine and Tyrosine | | 22772 | PTN | Phenytoin | Dilantin, DPH, Diphenylhydantoin | | | 22773 | PTN-F | Phenytoin, Free | Dilantin, Free Phenytoin | | | 26253 | BLPATCH | Phlebotomy Draw - Blood Patch | | | | 25221 | PSIGM | Phosphatidylserine IgM | | | | 26019 | PLA2RSO | Phospholipase A2 Recpt (PLA2R) | PLA2R, Anti-PLA2R | | | 22776 | PHOS | Phosphorus | PO4, Inorganic Phosphorus, Phos, Phosphate | | | 22775 | PHOS-O | Phosphorus, Body Fluid | Body Fluid Phosphorus, Phosphorus, Other | | | 22777 | PH-24H | Phosphorus, Urine 24 Hour | Phosphorus - Urine, 24hr | | | 22778 | PHOS-RU | Phosphorus, Urine Random | PO4-RU | | | 22779 | PINW | Pinworm | Enterobius vermicularis, Pinworm Paddle | | | 25240 | PIPASO | Pipecolic Acid, Serum (PIPA) | | | | 22645 | PLASMA | Plasma | FFP, Fresh Frozen Plasma | | | 24744 | PCPDFSO | Plasma Cell Proliferative Disorder FISH, Bone Marrow (PCPDS) | +1q or 1q22
17p- (17p deletion) or TP53
IGH (14q32) rearrangement
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Multiple Myeloma
Plasma Cell Leukemia
t(11;14) - CCND1/IGH
t(14;16) - IGH/MAF
t(14;20) - IGH/MAFB
t(4;14) - FGFR3/IGH | | | 25601 | PLASFSO | Plasma Cell Proliferative FISH, Tissue (PLASF) | +3/+7
+9/+15
13q- / -13 (13q deletion) or RB1
17p- (17p deletion) or TP53
-13 (monosomy 13)
IGH (14q32) rearrangement
Monoclonal Gammopathy of Unknown Significance (MGUS)
Multiple Myeloma
MYC (8q24.1) rearrangement
Plasma Cell Leukemia
t(4;14) - FGFR3/IGH
t(6;14) - CCND3/IGH
t(11;14) - CCND1/IGH
t(14;16) - IGH/MAF
t(14;20) - IGH/MAFB
+1q or 1q22
| | | 25542 | PLHBBSO | Plasma Hemoglobin (PLHBB) | Plasma Free Hemoglobin | | | 25464 | PLGSO | Plasminogen Activity, Plasma (PSGN) | Plasminogen, Functional, Plasma | | | 22784 | PLTAGG | Platelet Aggregation | | Agonsists tested: Epinephrine, ADP, Ristocetin, Collagen and Arachidonic Acid | | 24917 | APASO | Platelet Antibody Screen (5543) | Ref Lab Code: 5543, Anti-Platelet Antibodies | | | 22954 | PPR-PPS | Platelet Concentrate | SDP, Single Donor Platelet, Apheresis collected platelet | | | 22955 | PLT | Platelet Count | Thrombocyte | | | 22956 | PFT-EPI | Platelet Function Test | PFA-100, Platelet Function Assay-100 | | | 26161 | PLM6S | Platelet Mapping on TEG6S | PLM, PLM6S, Platelet Mapping ADP, Platelet Mapping AA | HKH-MA, ActFMA, ADP-MA, %INH-ADP, %AGG-ADP, AA-MA, %INH-AA, %AGG-AA | | 24998 | PMLSO | PML/RARA Quantitative, PCR (PMLR) | (15;17)(q22;q12), Acute myeloid leukemia (AML), Acute promyelocytic leukemia (APL), AML (acute myeloid leukemia), AMPL, APL minimum residual disease, PCR, PML/RARA, ABC | | | 25534 | MISC | PML-RARA Translocation, t(15;17) by RT-PCR, Quantitative (2002871) | AMPL' APL, APL MRD, APL Post-consolidation therapy testing, PML-RARA fusion types, A, B, B variant, PML-RARA long, short, variable types, PML-RARA S, L, V forms, PML_RARA fusion types, Quantitative PML, t(15;17) | | | 22958 | PNH-FC | PNH-Paroxysmal Nocturnal Hemoglobinuria | Flow Cytometry, CD55, CD59, Ham's Test for PNH, Sucrose Hemolysis Test | | | 25060 | POLIOSO | Poliovirus (Types 1, 3) Antibodies, Neutralization (FPOLO) | Polio Immune Status Panel, Polio Vaccine Response, Poliovirus | Polio 1, 3 Titers | | 22960 | PBG-QL | Porphobilinogen, Qualitative, Random Urine | PBG Qual | | | 26272 | PBGUSO | Porphobilinogen, Quantitative, Random, Urine (PBGU) | Acute Intermittent Porphyria (AIP)
Hereditary Coproporphyria (HCP)
PBG (Porphobilinogen)
Variegate Porphyria (VP) | | | 22962 | MISC | Porphyrin Evaluation, Whole Blood (PEE) | Erythrocyte Porphyrin, Erythropoietic Protoporphyria (EPP), Free Erythrocyte Porphyrin (FEP), Protoporphyrin, Protoporphyrins, Total, Erythrocytes, RBC Porphyrins, Red Blood Cell Porphyrins, X-linked Dominant Protoporpyria (XLDPP or XDP) | | | 23105 | PORPHU | Porphyrins, Quantitative, 24 Hr Urine (PQNU) | Acute Intermittent Porphyria (AIP)
Congenital Erythropoietic Porphyria (CEP)
Coproporphyrin
Hereditary Coproporphyria (HCP)
PBG (Porphobilinogen)
Porphyria Cutanea Tarda (PCT)
Porphyrins, Fractionation, Urine
Uroporphyrin
Variegate Porphyria (VP) | | | 25003 | POSACSO | Posaconazole, Serum (POSA) | Noxafil (Posaconazole), Posaconazole (Noxafil) | | | 22964 | K | Potassium | K, i-Stat Potassium | | | 22963 | K-O | Potassium, Other | .K-Other, Body Fluid Potassium | | | 22965 | K-24H | Potassium, Urine 24 Hour | K-24H | | | 22966 | K-RU | Potassium, Urine Random | Potassium-Rand Ur | | | 22967 | PREALB | Prealbumin | Thyroxine-binding prealbumin, transthyretin, PAB | | | 24816 | PGABSO | Pregabalin (PGN) | Lyrica® | | | 22968 | PGSER | Pregnancy Test, Stat | Pregnancy, HCG, Rapid | | | 22969 | PGQL | Pregnancy Test, Urine Qualitative | Rapid Slide Pregnancy Test, HCG, Urine, Qualitative | | | 25298 | PREGNSO | Pregnenolone, Serum (PREGN) | | | | 22972 | PRIMSO | Primidone (101) | Mysoline® | | | 26035 | PRIONSO | Prion Disease (CJD), CSF Panel | | | | 22973 | PROCSO | Procainamide and NAPA (PA) | NAPA (N-Acetyl Procainamide), Pronestyl (Procainamide), N-Acetyl Procainamide | | | 25166 | PCT | Procalcitonin, Serum | | | | 25679 | PINPSO | Procollagen I Intact N-Terminal, Serum (PINP) | | | | 22974 | PROGES | Progesterone | P4 | | | 23352 | PROINSO | Proinsulin, Plasma (PINS) | Proinsulin, P | | | 22975 | PROLAC | Prolactin | | | | 25540 | PROLSO | Prolaris Prostate, Tissue | Prostate Cancer Screen | | | 25486 | FPGD2SO | Prostaglandin D2 (FD2PG) | PGD2, FD2PG, Prostaglandins, Prostaglandins PGD2 | | | 22981 | PROT-CF | Protein C Activity (Functional) | | | | 22229 | | Protein C Antigen | | | | 22983 | PROT-CM | Protein C Antigen, On Coumadin (300067) | Protein C Antigen, Protein C Antigen / Factor VII ratio | Test includes Protein C antigen, Factor VII antigen, and Prot C/Factor VII ratio. | | 22993 | PEP | Protein electrophoresis (PEP), Serum | PEP, Protein electrophoresis - Blood | Total protein, Albumin, Alpha-1, Alpha-2, Beta, and Gamma globulins | | 22230 | | Protein S Antigen | | | | 22985 | PROTSI | Protein S Antigen, No Coumadin | | | | 22986 | PROT-SM | Protein S Antigen, On Coumadin (300059) | Protein S Antigen, Protein S Antigen/Factor VII Antigen Ratio | Test includes Protein S antigen, Factor VII antigen, and Prot S/Factor VII ratio. | | 22987 | TP-O | Protein, Body Fluid | Body Fluid Total Protein, TP-O | | | 22988 | CSFTP | Protein, CSF Fluid | Spinal Fluid Protein | | | 22989 | TP | Protein, Total | Protein, Total - Blood | | | 22172 | PROT-U | Protein, Urine | Urine Protein screen, Protein, Urine, Qualitative, Albumin, Urine Qualitative | | | 22990 | PRO-24H | Protein, Urine 24 Hour | Protein -24Hr Urine | Urine Protein and Creatinine | | 25124 | PRO-6H | Protein, Urine 6 Hour | Protein, Urine, Quantitative, 6 hours, 6 HR | Urine Protein and Creatinine | | 22991 | ORTHO | Protein, Urine, Orthostatic Proteinuria | Orthostatic Proteinuria | Urine Protein and Creatinine | | 22992 | PRO-CR | Protein/Creatinine Ratio, Urine | PR/CR, Random Urine Quantitative Protein | Urine Protein and Creatinine | | 23123 | PR3 | Proteinase 3 Antibody | Serine Protease 3, PR3 ANCA | | | 25507 | GAMPRIT | Protein-Immunotyping (PEP,GAM,IT) and Beta 2 Microglobulin | Gammopathy profile, Monoclonal gammopathy profile, IF-B2 panel, Quantitative immunoglobulins in serum (IgG, IgA and IgM) with serum protein electrophoresis and Beta-2 Microglobulin | IgG, IgA, IgM, Protein electrophoresis (Total Protein, Albumin, Alpha-1, Alpha-2, Beta and Gamma fractions), and Beta-2 Microglobulin. Immunotyping may be ordered by interpreter, at an additional charge. | | 25508 | IEPIT | Protein-Immunotyping (PEP,GAM,IT) Panel | IF Panel (if Immunotyping is required by interpreter), IEP, Immunoelectrophoresis panel - includes protein electrophoresis, immunoglobulins IgG, IgA and IgM and Immunotyping if needed) | Protein Electrophoresis (Total Protein, Albumin, Alpha-1, Alpha-2, Beta, and Gamma Globulins), Immunoglobulin IgG, IgA and IgM. Immunotyping, if required by interpreter (there is an additional charge for Immunotyping). | | 23001 | PTG | Prothrombin Gene Mutation | PTG 20210, Prothrombin Gene Mutation (PTG), Hypercoagulability,
Thrombophilia | | | 23002 | PT | Prothrombin Time - INR | Protime, PT, INR, i-Stat PT/INR, CSPT, CS PT, Code Stroke PT, Code Stroke Protime | | | 22643 | MISC | Protoporphyrins, Fractionation, Erythrocytes (PPFE) | EPP (Erythropoietic Protoporphyria), Erythropoietic Protoporphyria, Free Protoporphyrin, Zinc Protoporphyrin, X-linked Dominant Protoporphyria (XLDPP or XDP) | | | 23003 | MISC | Protriptyline (110) | Vivactyl® | | | 23004 | PSA-F | PSA, Free & Total | Prostate Specific Antigen, Free & Total | Total Prostate Specific Antigen , Free Prostate Specific Antigen | | 23005 | PSA | PSA, Total | Prostate Specific Antigen, Total | | | 24892 | PCHOTSO | Pseudocholinesterase, Total (PCHE1) | Cholinesterase (Pseudo), Total, Serum Cholinesterase (Pseudochol), Butyrylcholinesterase | | | 25117 | PTH-O | PTH, Intact - Other Fluids | FNA, Fine Needle Aspirate, Parathyroid Hormone, Fluid, Cyst, PTH | | | 22925 | INT-PTH | PTH, Intact With Calcium | Intact PTH, I-PTH, CA-PTH with minerals | Parathyroid Hormone, Calcium | | 23274 | PTHWOC | PTH, Intact, Without Calcium | | | | 23250 | PTHRSO | PTH-Related Peptide (PTHRP) | Humoral Hypercalcemia of Malignancy Factor
Parathyroid Related Polypeptide
Parathyroid Related Protein
PRP
PTH Related Peptide
PTHRP, Plasma
PTH Related Protein
Parathyroid Hormone Related Peptide | | | 22847 | PYRUV | Pyruvate in Blood | Pyruvid Acid, Pyruvate in whole blood | | | 25658 | PYRSO | Pyruvic Acid, Blood (PYR) | ETC, Mitochondrial Electron Transport Chain Defects, Mitochondrial Respiratory Chain Disorders, PC, PDH (Pyruvate Dehydrogenase) Deficiency, PDHC (Pyruvate Dehydrogenase Complex), Pyruvate Carboxylase Deficiency, Pyruvate Decarboxylase Deficiency, Pyruvate Dehydrogenase (PDH) Deficiency, Pyruvate Dehydrogenase Complex (PDHC), blood pyruvate | | | 25603 | PYRCSO | Pyruvic Acid, CSF (PYRC) | ETC, Mitochondrial Electron Transport Chain Defects, Mitochondrial Respiratory Chain Disorders, PC, PDH (Pyruvate Dehydrogenase) Deficiency, PDHC (Pyruvate Dehydrogenase Complex), Pyruvate, Pyruvate Carboxylase Deficiency, Pyruvate Dehydrogenase (PDH) Deficiency, Pyruvate Dehydrogenase Complex (PDHC) | |
|